GL1X · GenesisL1 explorer

MolNFT v1 · #40590 · protein

Structure of apo-calmodulin bound to unconventional myosin V

2IX7: “Structure of apo-calmodulin bound to unconventional myosin V”. X-ray diffraction, 2 ligands (CYS, SO4), 4 pockets (best druggability 0.45). MolNFT v1 #40590 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
2IX7
Type
protein
Length
348 residues
Chains
3
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Calmodulin; Myosin-5A
UniProt
P62204, Q99104
Ligands
CYS, SO4
Pockets
4 · best druggability 0.45

Structure

x-ray diffraction · 2 distinct chains · 67% helix, 5% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BCalmodulinprotein14557% helix, 7% strandP62204
CMyosin-5Aprotein5893% helix, 0% strandQ99104

Ligands and binding sites

  • CYS · Cysteine · ligand · chains B, C
  • SO4 · Sulfate ion · ion · 5 copies · chains B, A, C

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11100.450.7922empty
2500.370.8014empty
3910.350.7415empty
4840.320.7317empty

Interfaces

3 interfaces between chains.

  • A–C · 1484 Ų buried · 15 hydrogen bonds · protein-protein
  • B–C · 1474 Ų buried · 23 hydrogen bonds · protein-protein
  • A–B · 257 Ų buried · 4 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 1 covalent (covalent ligand).

Compared structures

  • 2IX7 · Structure of apo-calmodulin bound to unconventional myosin V · the same entry in another collection · chain A against A, TM-score 1.00
  • Q99104 · AlphaFold monomer V2.0 prediction for unconventional myosin-va (Q99104) · a predicted model of the same protein · chain C against A, TM-score 0.91

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.